403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Nestle Broadens Recall of Baby Formula Following Updated Safety Limits
(MENAFN) Nestle on Tuesday announced that it is expanding a recall of its Guigoz baby formula brand in France to include an additional batch, following the country’s decision to lower the maximum allowable threshold for a known toxin.
In a written statement, Nestle France said, "Our quality standard is based on the strictest cereulide detection threshold in the industry: we aim for the total absence of detectable cereulide in our infant milks. This requirement, which guides all our decisions, leads us today to proceed with the additional recall of a single batch of Guigoz Optipro Relais 1 (0–6 months)."
The company clarified that no other Guigoz products are affected and emphasized that those products remain safe for consumption.
Cereulide, a toxin that can cause nausea, vomiting, and diarrhea, has prompted the recall of several Nestle baby food products in recent weeks.
In a written statement, Nestle France said, "Our quality standard is based on the strictest cereulide detection threshold in the industry: we aim for the total absence of detectable cereulide in our infant milks. This requirement, which guides all our decisions, leads us today to proceed with the additional recall of a single batch of Guigoz Optipro Relais 1 (0–6 months)."
The company clarified that no other Guigoz products are affected and emphasized that those products remain safe for consumption.
Cereulide, a toxin that can cause nausea, vomiting, and diarrhea, has prompted the recall of several Nestle baby food products in recent weeks.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment